The 22 references in paper R. Samsonov B., V. Burdakov S., T. Shtam A., Z. Radzhabova A., Y. Cheburkin V., D. Vasilyev A., E. Tsyrlina V., S. Titov E., M. Ivanov К., M. Filatov V., L. Berstein M., N. Kolesnikov N., А. Malek V., Р. Самсонов Б., В. Бурдаков С., Т. Штам А., Раджабова А. З., Ю. Чебуркин В., Д. Васильев А., Е. Цырлина В., С. Титoв Е., М. Иванов К., М. Филатов В., Л. Берштейн М., Н. Колесников Н., А. Малек В. (2017) “МЕТОД ДИФФЕРЕНЦИАЛЬНОЙ ДИАГНОСТИКИ УЗЛОВЫХ ЗАБОЛЕВАНИЙ ЩИТОВИДНОЙ ЖЕЛЕЗЫ: АНАЛИЗ КОМБИНАЦИИ МИКРОРНК (МИРНК-21, -181A И -146А) // ANALYSIS OF A MIRNA SET (MIR-21, -181A, AND -146A) AS A METHOD OF DIFFERENTIAL DIAGNOSIS OF THYROID NODULES” / spz:neicon:ogsh:y:2017:i:2:p:16-24

1
Валдина Е. А. Заболевания щитовидной железы. СПб.: Питер, 2013. [Valdina E. A. Diseases of the thyroid gland. Saint Petersburg: Piter, 2013. (In Russ.)].
(check this in PDF content)
2
Dean D. S., Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008;22(6):901–11. DOI: 10.1016/j.beem.2008.09.019. PMID: 19041821.
(check this in PDF content)
3
Luster M., Weber T., Verburg F. A. Differentiated thyroid cancer-personalized therapies to prevent overtreatment. Nat Rev Endocrinol 2014;10(9):563–74. DOI: 10.1038/nrendo.2014.100. PMID: 24981455.
(check this in PDF content)
4
Kato M. A., Fahey T. J. Molecular markers in thyroid cancer diagnostics. Surg Clin North Am 2009;89 (5):1139–55. DOI: 10.1016/j. suc. 2009.06.012. PMID: 19836489.
(check this in PDF content)
5
Zipeto M. A., Jiang Q., Melese E., Jamieson C. H. RNA rewriting, recoding, and rewiring in human disease. Trends Mol Med 2015;21(9):549–59. DOI: 10.1016/j.molmed.2015.07.001. PMID: 26259769.
(check this in PDF content)
6
Di Leva G., Garofalo M., Croce C. M. MicroRNAs in cancer. Ann Rev Pathol 2014;9:287–314. DOI: 10.1146/annurevpathol-012513–104715. PMID: 24079833.
(check this in PDF content)
7
Forte S., La Rosa C., Pecce V. et al. The role of microRNAs in thyroid carcinomas. Anticancer Res 2015;35(4):2037–47. PMID: 25862858.
(check this in PDF content)
8
Колесников Н. Н., Титов С. Е., Веряскина Ю. А. и др. МикроРНК, эволюция и рак. Цитология 2013; 55(3):159–64. [Kolesnikov N. N., Titov S. E., Veriaskina Iu. A. et al. MicroRNA, evolution, and cancer. Tsitologiia = Cytology 2013;55(3):159–64. (In Russ.)].
(check this in PDF content)
9
Nikiforova M. N., Chiosea S. I., Nikiforov Y. E. MicroRNA expression profiles in thyroid tumors. Endocr Pathol 2009;20(2):85–91. DOI: 10.1007/s12022-009-9069-z. PMID: 19352602.
(check this in PDF content)
10
Колесников Н. Н., Титов С. Е., Жимулев И. Ф. МикроРНК в диагностике рака. Наука в России 2013;6(198):27–33. [Kolesnikov N. N., Titov S. E., Zimulev I. F. MicroRNA in cancer diagnostics. Nauka v Rossii = Science in Russia 2013;6 (198):27–33. (In Russ.)].
(check this in PDF content)
11
Sato-Kuwabara Y., Melo S. A., Soares F. A., Calin G. A. The fusion of two worlds: non-coding RNAs and extracellular vesicles-diagnostic and therapeutic implications (Review). Int J Oncol 2015;46(1):17–27. DOI: 10.3892/ijo.2014.2712. PMID: 25338714.
(check this in PDF content)
12
Zhang J., Li S., Li L. et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics 2015;13(1):17–24. DOI: 10.1016/j.gpb.2015.02.001. PMID: 25724326.
(check this in PDF content)
13
Малек А. М., Берштейн Л. М., Филатов М. В., Беляев А. М. Система экзосомальных межклеточных коммуникаций и ее роль в процессе метастатической диссеминации. Вопросы онкологии 2014;60(4):429–36. [Malek A. V., Berstein L. M., Filatov M. V., Belyaev A. M. System of exosomal cell communications and its role in the process of metastatic dissemination. Voprosy onkologii = Problems in Oncology 2014;60(4): 429–36]. (In Russ.)].
(check this in PDF content)
14
Ye S. B., Li Z. L., Luo D. H. et al. Tumorderived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget 2014;5(14):5439–52. DOI: 10.18632/oncotarget.2118. PMID: 24978137.
(check this in PDF content)
15
Rana S., Malinowska K., Zoller M. Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia 2013;15(3):281–95. PMID: 23479506.
(check this in PDF content)
16
Challagundla K. B., Wise P. M., Neviani P. et al. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst 2015;107(7). DOI: 10.1093/jnci/djv135. PMID: 25972604.
(check this in PDF content)
17
Yu S., Liu Y., Wang J. et al. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 2012;97 (6):2084–92. DOI: 10.1210/jc.2011–3059. PMID: 22472564.
(check this in PDF content)
18
Lee J. C., Zhao J. T., Clifton-Bligh R. J. et al. MicroRNA-222 and microRNA146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer 2013;119(24):4358–65. DOI: 10.1002/cncr.28254. PMID: 24301304.
(check this in PDF content)
19
Lee Y. S., Lim Y. S., Lee J. C. et al. Differential expression levels of plasmaderived miR-146b and miR-155 in papillary thyroid cancer. Oral Oncol
(check this in PDF content)
20
5;51 (1):77–83. DOI: 10.1016/j.oraloncology.2014.10.006. PMID: 25456009. 20. Ferracin M., Lupini L., Salamon I. et al. Absolute quantification of cell-free microRNAs in cancer patients. Oncotarget 2015;6(16):14545–55. DOI: 10.18632/oncotarget.3859. PMID: 26036630.
(check this in PDF content)
21
Chevillet J. R., Kang Q., Ruf I. K. et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci USA 2014;111(41):14888–93. DOI: 10.1073/pnas.1408301111. PMID: 25267620.
(check this in PDF content)
22
Cha D. J., Franklin J. L., Dou Y. et al. KRAS-dependent sorting of miRNA to exosomes. Elife 2015;1(4): e07197. DOI: 10.7554/eLife.07197. PMID: 26132860.
(check this in PDF content)